MERS, SARS and other coronaviruses as causes of pneumonia

Yudong Yin, Richard G Wunderink, Yudong Yin, Richard G Wunderink

Abstract

Human coronaviruses (HCoVs) have been considered to be relatively harmless respiratory pathogens in the past. However, after the outbreak of the severe acute respiratory syndrome (SARS) and emergence of the Middle East respiratory syndrome (MERS), HCoVs have received worldwide attention as important pathogens in respiratory tract infection. This review focuses on the epidemiology, pathogenesis and clinical characteristics among SARS-coronaviruses (CoV), MERS-CoV and other HCoV infections.

Keywords: Middle East respiratory syndrome; human coronaviruses; pneumonia; severe acute respiratory syndrome.

© 2017 Asian Pacific Society of Respirology.

References

    1. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv. Virus Res. 2011; 81: 85–164.
    1. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003; 348: 1967–76.
    1. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012; 367: 1814–20.
    1. World Health Organization . WHO Guidelines for the Global Surveillance of Severe Acute Respiratory Syndrome (SARS) Updated recommendations, October 2004. [Accessed 28 Aug 2017] Available from URL: .
    1. World Health Organization . Middle East Respiratory Syndrome Coronavirus (MERS‐CoV) Fact Sheet [Accessed 28 Aug 2017.] Available from URL: .
    1. Woo PC, Lau SK, Lam CS, Lau CC, Tsang AK, Lau JH, Bai R, Teng JL, Tsang CC, Wang M et al. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J. Virol. 2012; 86: 3995–4008.
    1. Huynh J, Li S, Yount B, Smith A, Sturges L, Olsen JC, Nagel J, Johnson JB, Agnihothram S, Gates JE et al. Evidence supporting a zoonotic origin of human coronavirus strain NL63. J. Virol. 2012; 86: 12816–25.
    1. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003; 302: 276–8.
    1. Azhar EI, El‐Kafrawy SA, Farraj SA, Hassan AM, Al‐Saeed MS, Hashem AM, Madani TA. Evidence for camel‐to‐human transmission of MERS coronavirus. N. Engl. J. Med. 2014; 370: 2499–505.
    1. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, Wang H, Crameri G, Hu Z, Zhang H et al. Bats are natural reservoirs of SARS‐like coronaviruses. Science 2005; 310: 676–9.
    1. Ithete NL, Stoffberg S, Corman VM, Cottontail VM, Richards LR, Schoeman MC, Drosten C, Drexler JF, Preiser W. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg. Infect. Dis. 2013; 19: 1697–9.
    1. Woo PC, Lau SK, Li KS, Poon RW, Wong BH, Tsoi HW, Yip BC, Huang Y, Chan KH, Yuen KY. Molecular diversity of coronaviruses in bats. Virology 2006; 351: 180–7.
    1. Lau SK, Woo PC, Li KS, Tsang AK, Fan RY, Luk HK, Cai JP, Chan KH, Zheng BJ, Wang M et al. Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A. J. Virol. 2015; 89: 3076–92.
    1. Hunter JC, Nguyen D, Aden B, Al Bandar Z, Al Dhaheri W, Abu Elkheir K, Khudair A, Al Mulla M, El Saleh F, Imambaccus H et al. Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi. Emerg. Infect. Dis. 2016; 22: 647–56.
    1. Korea Centers for Disease Control and Prevention . Middle East Respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res. Perspect. 2015; 6: 269–78.
    1. Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, Leung GM, Lam TH, Hedley AJ. Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2004; 359: 1091–105.
    1. Kang CK, Song KH, Choe PG, Park WB, Bang JH, Kim ES, Park SW, Kim HB, Kim NJ, Cho SI et al. Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 Outbreak in Korea. J. Korean Med. Sci. 2017; 32: 744–9.
    1. Moon SY, Son JS. Infectivity of an asymptomatic patient with Middle East respiratory syndrome coronavirus infection. Clin. Infect. Dis. 2017; 64: 1457–8.
    1. Woo PC, Lau SK, Yuen KY. Clinical features and molecular epidemiology of coronavirus‐HKU1‐associated community‐acquired pneumonia. Hong Kong Med. J. 2009; 15 (Suppl. 9): 46–7.
    1. Skowronski DM, Astell C, Brunham RC, Low DE, Petric M, Roper RL, Talbot PJ, Tam T, Babiuk L. Severe acute respiratory syndrome (SARS): a year in review. Annu. Rev. Med. 2005; 56: 357–81.
    1. Assiri A, Al‐Tawfiq JA, Al‐Rabeeah AA, Al‐Rabiah FA, Al‐Hajjar S, Al‐Barrak A, Flemban H, Al‐Nassir WN, Balkhy HH, Al‐Hakeem RF et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013; 13: 752–61.
    1. Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, Hawa H, Alothman A, Khaldi A, Al Raiy B. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann. Intern. Med. 2014; 160: 389–97.
    1. Alraddadi BM, Watson JT, Almarashi A, Abedi GR, Turkistani A, Sadran M, Housa A, Almazroa MA, Alraihan N, Banjar A et al. Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014. Emerg. Infect. Dis. 2016; 22: 49–55.
    1. Park SH, Kim YS, Jung Y, Choi SY, Cho NH, Jeong HW, Heo JY, Yoon JH, Lee J, Cheon S et al. Outbreaks of Middle East respiratory syndrome in two hospitals initiated by a single patient in Daejeon, South Korea. Infect. Chemother. 2016; 48: 99–107.
    1. Mailles A, Blanckaert K, Chaud P, van der Werf S, Lina B, Caro V, Campese C, Guery B, Prouvost H, Lemaire X et al. Investigation Team . First cases of Middle East Respiratory Syndrome Coronavirus (MERS‐CoV) infections in France, investigations and implications for the prevention of human‐to‐human transmission, France, May 2013. Euro Surveill. 2013; 18: pii 20502.
    1. Lau SK, Woo PC, Yip CC, Tse H, Tsoi HW, Cheng VC, Lee P, Tang BS, Cheung CH, Lee RA et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J. Clin. Microbiol. 2006; 44: 2063–71.
    1. Woo PC, Yuen KY, Lau SK. Epidemiology of coronavirus‐associated respiratory tract infections and the role of rapid diagnostic tests: a prospective study. Hong Kong Med. J. 2012; 18 (Suppl. 2): 22–4.
    1. Lee WJ, Chung YS, Yoon HS, Kang C, Kim K. Prevalence and molecular epidemiology of human coronavirus HKU1 in patients with acute respiratory illness. J. Med. Virol. 2013; 85: 309–14.
    1. Johnstone J, Majumdar SR, Fox JD, Marrie TJ. Viral infection in adults hospitalized with community‐acquired pneumonia: prevalence, pathogens, and presentation. Chest 2008; 134: 1141–8.
    1. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM et al. Community‐acquired pneumonia requiring hospitalization among U.S. adults. N. Engl. J. Med. 2015; 373: 415–27.
    1. Cao B, Ren LL, Zhao F, Gonzalez R, Song SF, Bai L, Yin YD, Zhang YY, Liu YM, Guo P et al. Viral and Mycoplasma pneumoniae community‐acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China. Eur. J. Clin. Microbiol. Infect. Dis. 2010; 29: 1443–8.
    1. Gallagher TM, Buchmeier MJ. Coronavirus spike proteins in viral entry and pathogenesis. Virology 2001; 279: 371–4.
    1. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC et al. Angiotensin‐converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426: 450–4.
    1. Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pohlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 7988–93.
    1. Imai Y, Kuba K, Ohto‐Nakanishi T, Penninger JM. Angiotensin‐converting enzyme 2 (ACE2) in disease pathogenesis. Circ. J. 2010; 74: 405–10.
    1. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong‐Poi H et al. Angiotensin‐converting enzyme 2 protects from severe acute lung failure. Nature 2005; 436: 112–6.
    1. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus‐induced lung injury. Nat. Med. 2005; 11: 875–9.
    1. Meyerholz DK, Lambertz AM, PB MC Jr. Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the Middle East respiratory syndrome. Am J Pathol. 2016; 186: 78–86.
    1. Widagdo W, Raj VS, Schipper D, Kolijn K, van Leenders GJ, Bosch BJ, Bensaid A, Segales J, Baumgartner W, Osterhaus AD et al. Differential expression of the Middle East respiratory syndrome coronavirus receptor in the upper respiratory tracts of humans and dromedary camels. J. Virol. 2016; 90: 4838–42.
    1. Boonacker E, Van Noorden CJ. The multifunctional or moonlighting protein CD26/DPPIV. Eur. J. Cell Biol. 2003; 82: 53–73.
    1. Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 1992; 357: 420–2.
    1. Menachery VD, Eisfeld AJ, Schafer A, Josset L, Sims AC, Proll S, Fan S, Li C, Neumann G, Tilton SC et al. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon‐stimulated gene responses. MBio 2014; 5: e01174–14.
    1. Lau SK, Lau CC, Chan KH, Li CP, Chen H, Jin DY, Chan JF, Woo PC, Yuen KY. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J. Gen. Virol. 2013; 94: 2679–90.
    1. Chan JF, Chan KH, Choi GK, To KK, Tse H, Cai JP, Yeung ML, Cheng VC, Chen H, Che XY et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J. Infect. Dis. 2013; 207: 1743–52.
    1. Yoshikawa T, Hill TE, Yoshikawa N, Popov VL, Galindo CL, Garner HR, Peters CJ, Tseng CT. Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome‐associated coronavirus infection. PLoS One 2010; 5: e8729.
    1. Kaye M. SARS‐associated coronavirus replication in cell lines. Emerg. Infect. Dis. 2006; 12: 128–33.
    1. World Health Organization . Clinical Management of Severe Acute Respiratory Infection When Middle East Respiratory Syndrome Coronavirus (MERS‐CoV) Infection Is Suspected [Accessed 28 Aug 2017.] Available from URl: .
    1. Memish ZA, Al‐Tawfiq JA, Makhdoom HQ, Assiri A, Alhakeem RF, Albarrak A, Alsubaie S, Al‐Rabeeah AA, Hajomar WH, Hussain R et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J. Infect. Dis. 2014; 210: 1590–4.
    1. Chan JF, Sridhar S, Yip CC, Lau SK, Woo PC. The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic. J. Microbiol. 2017; 55: 172–82.
    1. Chan KS, Zheng JP, Mok YW, Li YM, Liu YN, Chu CM, Ip MS. SARS: prognosis, outcome and sequelae. Respirology 2003; 8(Suppl): S36–40.
    1. Nunes MC, Kuschner Z, Rabede Z, Madimabe R, Van Niekerk N, Moloi J, Kuwanda L, Rossen JW, Klugman KP, Adrian PV et al. Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV‐infected and HIV‐uninfected South African children. PLoS One 2014; 9: e86448.
    1. Garbino J, Crespo S, Aubert JD, Rochat T, Ninet B, Deffernez C, Wunderli W, Pache JC, Soccal PM, Kaiser L. A prospective hospital‐based study of the clinical impact of non‐severe acute respiratory syndrome (Non‐SARS)‐related human coronavirus infection. Clin. Infect. Dis. 2006; 43: 1009–15.
    1. Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, Fung KS, Tang HL, Yan WW, Chan HW et al. Acute renal impairment in coronavirus‐associated severe acute respiratory syndrome. Kidney Int. 2005; 67: 698–705.
    1. Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, Selim MA, Al Mutairi M, Al Nakhli D, Al Aidaroos AY et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single‐center experience in Saudi Arabia. Int. J. Infect. Dis. 2014; 29: 301–6.
    1. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS et al. Clinical progression and viral load in a community outbreak of coronavirus‐associated SARS pneumonia: a prospective study. Lancet 2003; 361: 1767–72.
    1. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P et al. Clinical features and short‐term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289: 2801–9.
    1. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, To KF et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003; 348: 1986–94.
    1. Almekhlafi GA, Albarrak MM, Mandourah Y, Hassan S, Alwan A, Abudayah A, Altayyar S, Mustafa M, Aldaghestani T, Alghamedi A et al. Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients. Crit. Care 2016; 20: 123.
    1. Wong KT, Antonio GE, Hui DS, Lee N, Yuen EH, Wu A, Leung CB, Rainer TH, Cameron P, Chung SS et al. Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. Radiology 2003; 228: 401–6.
    1. Choi WS, Kang CI, Kim Y, Choi JP, Joh JS, Shin HS, Kim G, Peck KR, Chung DR, Kim HO et al.; Korean Society of Infectious Diseases . Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea. Infect. Chemother. 2016; 48: 118–26.
    1. Das KM, Lee EY, Al Jawder SE, Enani MA, Singh R, Skakni L, Al‐Nakshabandi N, AlDossari K, Larsson SG. Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients. Am. J. Roentgenol. 2015; 205: W267–74.
    1. Das KM, Lee EY, Enani MA, AlJawder SE, Singh R, Bashir S, Al‐Nakshbandi N, AlDossari K, Larsson SG. CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus. Am. J. Roentgenol. 2015; 204: 736–42.
    1. Morgenstern B, Michaelis M, Baer PC, Doerr HW, Cinatl J Jr. Ribavirin and interferon‐beta synergistically inhibit SARS‐associated coronavirus replication in animal and human cell lines. Biochem. Biophys. Res. Commun. 2005; 326: 905–8.
    1. Al‐Tawfiq JA, Momattin H, Dib J, Memish ZA. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int. J. Infect. Dis. 2014; 20: 42–6.
    1. Omrani AS, Saad MM, Baig K, Bahloul A, Abdul‐Matin M, Alaidaroos AY, Almakhlafi GA, Albarrak MM, Memish ZA, Albarrak AM. Ribavirin and interferon alfa‐2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect. Dis. 2014; 14: 1090–5.
    1. von Grotthuss M, Wyrwicz LS, Rychlewski L. mRNA cap‐1 methyltransferase in the SARS genome. Cell 2003; 113: 701–2.
    1. Chan JF, Chan KH, Kao RY, To KK, Zheng BJ, Li CP, Li PT, Dai J, Mok FK, Chen H, Hayden FG, Yuen KY. Broad‐spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J. Infect. 2013; 67: 606–16.
    1. Loutfy MR, Blatt LM, Siminovitch KA, Ward S, Wolff B, Lho H, Pham DH, Deif H, LaMere EA, Chang M et al. Interferon alfacon‐1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 2003; 290: 3222–8.
    1. Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, Kao RY, Poon LL, Wong CL, Guan Y et al. HKU/UCH SARS Study Group . Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004; 59: 252–6.
    1. Chan JF, Yao Y, Yeung ML, Deng W, Bao L, Jia L, Li F, Xiao C, Gao H, Yu P et al. Treatment with lopinavir/ritonavir or interferon‐beta1b improves outcome of MERS‐CoV infection in a nonhuman primate model of common marmoset. J. Infect. Dis. 2015; 212: 1904–13.
    1. Hart BJ, Dyall J, Postnikova E, Zhou H, Kindrachuk J, Johnson RF, Olinger GG Jr, Frieman MB, Holbrook MR, Jahrling PB et al. Interferon‐beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell‐based assays. J. Gen. Virol. 2014; 95: 571–7.
    1. Mair‐Jenkins J, Saavedra‐Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen‐Van‐Tam JS, Beck CR et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta‐analysis. J. Infect. Dis. 2015; 211: 80–90.
    1. Arabi Y, Balkhy H, Hajeer AH, Bouchama A, Hayden FG, Al‐Omari A, Al‐Hameed FM, Taha Y, Shindo N, Whitehead J et al. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus 2015; 4: 709.
    1. Lee N, Allen Chan KC, Hui DS, Ng EK, Wu A, Chiu RW, Wong VW, Chan PK, Wong KT, Wong E et al. Effects of early corticosteroid treatment on plasma SARS‐associated Coronavirus RNA concentrations in adult patients. J. Clin. Virol. 2004; 31: 304–9.
    1. Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Coronaviruses ‐ drug discovery and therapeutic options. Nat. Rev. Drug Discov. 2016; 15: 327–47.
    1. Agrawal AS, Ying T, Tao X, Garron T, Algaissi A, Wang Y, Wang L, Peng BH, Jiang S, Dimitrov DS et al. Passive transfer of a germline‐like neutralizing human monoclonal antibody protects transgenic mice against lethal Middle East respiratory syndrome coronavirus infection. Sci. Rep. 2016; 6: 31629.
    1. Tao X, Mei F, Agrawal A, Peters CJ, Ksiazek TG, Cheng X, Tseng CT. Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus. J. Virol. 2014; 88: 3902–10.
    1. Ohnuma K, Haagmans BL, Hatano R, Raj VS, Mou H, Iwata S, Dang NH, Bosch BJ, Morimoto C. Inhibition of Middle East respiratory syndrome coronavirus infection by anti‐CD26 monoclonal antibody. J. Virol. 2013; 87: 13892–9.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit